​Research and education are important aspects of modern cancer care. The radiation oncology medical physics team has a research focus to utilise modern imaging and radiation delivery techniques to improve the accuracy of patient treatment. This focus is aimed at providing safe delivery of the high doses of radiation required to provide optimum care for patients.

The radiation oncology team is a world leader in adaptive radiotherapy; enabling our clinicians to adapt the treatment during delivery. We have pioneered real-time adaptive radiotherapy for prostate and lung cancer to continuously target lesions that move while you breathe.

We are pioneering artificial intelligence driven radiotherapy enabling us to provide the best daily treatment for a range of cancers. The team members participate in a large number of clinical trials using state of the art technologies to treat patients. The team has research partnership locally with the Universities of Sydney, Wollongong and Newcastle; internationally with Aarhus University Hospital, University of Michigan and Brigham's and Women's Hospital; and also a commercial collaboration with Varian Medical Systems. NSCC is a reference site for Sun Nuclear Corporation. NSCC is part of the Varian Medical Systems Advanced Intelligence Consortium (AIC) of early adopters of the Ethos platform collaborating and contributing to international practice standards. The radiation oncology medical physicist uses scientific research and technical expertise to help improve the quality and safe delivery of radiation used for cancer treatment.